Retatrutide, by Soma Chems , represents a significant advance in metabolic regulation. This dual-action compound combines incretin receptor activity with GIP pathway stimulation , demonstrating remarkable results in trial findings for weight improvement. Scientists believe the drug is expected to represent a new pathway for people struggling with o